Lung Ultrasound for Physiotherapy in Hospitalized Patients With Respiratory Complications

Respiratory Complication Clinical Trial

Official title:

The Value of Point-of-care Lung Ultrasound for Physiotherapy in Hospitalized Patients With Acute Respiratory Symptoms

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06412081
• Other study ID #: LUS-physio
• Status: Recruiting
• Start date: May 10, 2024
• Est. completion date: August 30, 2024

Study information

• Verified date: June 2024
• Source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Contact: William Poncin
• Phone: +3227642316
• Email: william.poncin[@]uclouvain.be
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to evaluate the relevance of using point-of-care lung ultrasound (LUS) in modifying the physiotherapist's treatment plan for patients hospitalized in a general ward.

Description:

Hospitalized patients often confront respiratory issues stemming from diverse causes, such as pneumonia. Physiotherapists rely on a range of clinical and imaging data to inform their treatment decisions. Yet, they face challenges due to the absence of readily accessible, sensitive, specific, and reliable measurements to tailor the most effective physical therapeutic interventions based on individual clinical scenarios. Point-of-care Lung Ultrasound (LUS) holds promise in addressing these existing gaps.

This study aims to evaluate the impact of integrating LUS into clinical practice by comparing physiotherapists' initial clinical assessments and treatment plans with those made after incorporating LUS findings in patients admitted to a general ward.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: August 30, 2024
• Est. primary completion date: August 30, 2024
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hospitalization in a general ward

• Acute respiratory symptoms (< 48h)

• Chest X-ray available within 24h before or after the use of LUS

Exclusion Criteria:

• Any conditions precluding the use of LUS (thoracic skin lesions, thoracic bandage, subcutaneous emphysema)

• Inability to understand instructions due to cognitive impairment or due to language barrier

Related Conditions & MeSH terms

• Respiratory Complication

Locations

Country	Name	City	State
Belgium	Cliniques universitaires Saint-Luc	Brussels

Sponsors (1)

Lead Sponsor	Collaborator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of change of treatment plan	Relative change of treatment plan after the results of LUS in relation to the total number of events	Before and Immediately after the use of LUS (10-min interval)
Secondary	Agreement between the events observed on LUS and the events observed on Chest X-Ray	Number of concordant findings between LUS and Chest X-Ray. Each pair of tests will be rated as "positive" (same findings are observed between LUS and Chest X-Ray) or "negative" (findings are different).	At baseline